June 23, 2020 / 11:26 AM / 19 days ago

BRIEF-FibroGen Announces First Patient Enrolled In Pamrevlumab Clinical Trial For Acute Covid-19

June 23 (Reuters) - FibroGen Inc:

* FIBROGEN ANNOUNCES FIRST PATIENT ENROLLED IN PAMREVLUMAB CLINICAL TRIAL IN PATIENTS HOSPITALIZED IN U.S. WITH ACUTE COVID-19

* FIBROGEN - MULTICENTER TRIAL IS BEING CONDUCTED IN U.S. AND WILL ENROLL APPROXIMATELY 130 PATIENTS WITH COVID-19 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below